Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | EGCG |
Synonyms | |
Therapy Description |
EGCG (Epigallocatechin-3-gallate), inhibits fatty acid synthase (FASN), resulting in apoptosis in FASN over expressing cancer cells (PMID: 27106068, PMID: 17902053, PMID: 32660101). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EGCG | Epigallocatechin-3-gallate|Epigallocatechin gallate | FASN Inhibitor 5 | EGCG (Epigallocatechin-3-gallate), inhibits fatty acid synthase (FASN), resulting in apoptosis in FASN over expressing cancer cells (PMID: 27106068, PMID: 17902053, PMID: 32660101). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|